Survey
Tumor suppressor activity of the TGF-β pathway in human cancers

https://doi.org/10.1016/1359-6101(96)00001-9Get rights and content

Abstract

The TGF-βs are a family of cytokines with antiproliferative activity on many cell types. Recent findings demonstrate that the TGF-β receptor complex functions as a tumor suppressor gene in human malignancy. Somatic mutations of the type II subunit of the TGF-β receptor (RII) have been demonstrated in several different tumor types. RII frameshift mutations within a short coding region polyadenine repeat are particularly characteristic of colon and gastric cancers that also demonstrate the phenotype of microsatellite instability (RER cancers). These and other mutations as in the type I receptor (RI) are associated with both loss of cell surface TGF-β receptors and with resistance of the cancer cells to TGF-β-induced growth inhibition. Restoration of receptor expression by gene transfection reverses the transformed phenotype in cancer cells that lacked functional RII or RI. These receptors and, by implication, TGF-β as well as its complete signaling pathway, are thus new and novel additions to the family of human tumor suppressor genes.

References (123)

  • N Hoosein et al.

    Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-β1

    Exp Cell Res

    (1989)
  • H Lin et al.

    Expression cloning of the TGF-β type II receptor a functional transmembrane serine/threonine kinase

    Cell

    (1992)
  • J Wrana et al.

    TGFβ signals through a heteromeric protein kinase receptor complex

    Cell

    (1992)
  • A Moustakas et al.

    The transforming growth factor β receptors types 1, 11, and III form hetero-oligomeric complexes in the presence of ligand

    J Biol Chem

    (1993)
  • M Laiho et al.

    Responsiveness to transforming growth factor-β restored by genetic complementation between cells defective in TGF-β receptors I and II

    J Biol Chem

    (1991)
  • M Laiho et al.

    Concomitant loss of transforming growth factor (TGF)-β receptor types I and II in TGF-β-resistant cell mutants implicates both receptor types in signal transduction

    J Biol Chem

    (1990)
  • F López-Casillas et al.

    Betaglycan presents ligand to the TGFβ signaling receptor

    Cell

    (1993)
  • P Franzén et al.

    Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor

    Cell

    (1993)
  • T Brand et al.

    Inactive type II and type I receptors for TGFβ are dominant inhibitors of TGFβ-dependent transcription

    J Biol Chem

    (1995)
  • R Fishel et al.

    The human mutator gene homolog MSH2 and its association with hereditary non-polyposis colon cancer

    Cell

    (1993)
  • F Leach et al.

    Mutations of a Muts homolog in hereditary non-polyposis colorectal cancer

    Cell

    (1993)
  • LA Falk et al.

    Induction of transforming growth factor-beta I (TGF-beta 1), receptor expression and TGF-beta 1 protein production in retinoic acid-treated HL-60 cells: possible TGF-beta 1-mediated autocrine inhibition

    Blood

    (1991)
    LA Falk et al.

    Induction of transforming growth factor-beta I (TGF-beta 1), receptor expression and TGF-beta 1 protein production in retinoic acid-treated HL-60 cells: possible TGF-beta 1-mediated autocrine inhibition

    Blood

    (1991)
  • JJ Letterio et al.

    Novel vitamin D analog enhances differentiating effects of transforming growth factor beta-1 (TGF-β) in myeloid leukemic cell lines

  • S Markowitz et al.

    Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability

    Science

    (1995)
  • L Myeroff et al.

    A TGF-beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability

    Cancer Res

    (1995)
  • R Parsons et al.

    Microsatellite instability and mutations of the TGF-β type 11 receptor gene in colorectal cancer

    Cancer Res

    (1995)
  • L Garrigue-Antar et al.

    Mis-sense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells

    Cancer Res

    (1995)
  • J Park et al.

    Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β

  • A Roberts et al.

    Peptide growth factors and their receptors

  • J Massagué

    The transforming growth factor-beta family

    Ann Rer Cell Biol

    (1990)
  • MB Sporn et al.

    Autocrine growth factors and cancer

    Nature

    (1985)
  • M Shull et al.

    Targeted disruption of the mouse transforming growth factor-β gene results in multifocal inflammatory disease

    Nature

    (1992)
  • AB Kulkarni et al.

    Transforming growth factor beta I null mutation in mice causes excessive inflammatory response and early death

  • J Filmus et al.

    Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-β during tumor progression

    Curr Opin Oncol

    (1993)
  • M Alexandrow et al.

    Transforming growth factor β and cell cycle regulation

    Cancer Res

    (1995)
  • F Oberhammer et al.

    Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β

  • CY Wang et al.

    TGF-β and substrate release are both inducers of apoptosis in a human colon adenoma cell line

    Cancer Res

    (1995)
  • S Huang et al.

    Regulation of tibronectin and laminin receptor expression, fibronectin and laminin secretion in human colon cancer cells by transforming growth factor-β1

    Int J Cancer

    (1994)
  • S Chakrabarty

    Role of protein kinase C in transforming growth factor β induction of carcinoembryonic antigen in human colon carcinoma cells

    J Cell Physiol

    (1992)
  • M Alexandrow et al.

    Transforming growth factor β1 inhibits mouse keratinocytes late in GI independent of effects of gene transcription

    Cancer Res

    (1995)
  • S Markowitz et al.

    A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumori genicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene

    J Clin Invest

    (1994)
  • P Martikainen et al.

    Effect of transforming growth factor-β on proliferation and death of rat prostatic cells

    Endocrinology

    (1990)
  • A Avery et al.

    TGF-β expression in the human colon: differential immunostaining along crypt epithelium

    Br J Cancer

    (1993)
  • M Lipkin

    Intermediate biomarkers of increased susceptibility to cancers of the large intestine

  • Y Gavrieli et al.

    Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

    J Cell Biol

    (1992)
  • D Pierce et al.

    Mammary tumor suppression by transforming growth factor β1 transgene expression

  • C Jhappan et al.

    Targeting expression of a transforming growth factor β transgene to the pregnant mammary gland inhibits alveolar development and lactation

    EMBO J

    (1993)
  • K Sellheyer et al.

    Inhibition of skin development by overexpression of transforming growth factor β1 in the epidermis of transgenic mice

  • Y Geng et al.

    Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases

  • P Howe et al.

    Transforming growth factor β1 inhibition of p34cdc2 phosphorylation and histone HI kinase activity is associated with G/S-phase growth arrest

    Mol Cell Biol

    (1991)
  • Cited by (0)

    View full text